North America Glycomics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Enzymes, Instruments, Kits, and Reagents), Application (Drug Discovery and Development, Diagnostics, Immunology, Cancer, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations)

No. of Pages: 170    |    Report Code: BMIRE00027262    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Glycomics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Glycomics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Glycomics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in demand for high-quality oligosaccharides
  • 5.1.2 Rise in research on glycan profiling
5.2 Market Opportunities
  • 5.2.1 Growth in glycomics research and diagnostics
  • 5.2.2 Expansion in biopharmaceutical applications
5.3 Future Trends
  • 5.3.1 Increase in glycomic profiling applications
  • 5.3.2 Growth in therapeutic glycomics research
5.4 Impact of Drivers and Restraints

6. North America Glycomics Market Regional Analysis

6.1 North America Glycomics Market Overview
6.2 North America Glycomics Market Revenue 2020-2028 (US$ Million)
6.3 North America Glycomics Market Forecast Analysis

7. North America Glycomics Market Analysis – by Product

7.1 Enzymes
  • 7.1.1 Overview
  • 7.1.2 Enzymes: North America Glycomics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
  • 7.2.1 Overview
  • 7.2.2 Instruments: North America Glycomics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Kits
  • 7.3.1 Overview
  • 7.3.2 Kits: North America Glycomics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Reagents
  • 7.4.1 Overview
  • 7.4.2 Reagents: North America Glycomics Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Glycomics Market Analysis – by Application

8.1 Drug Discovery and Development
  • 8.1.1 Overview
  • 8.1.2 Drug Discovery and Development: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Diagnostics
  • 8.2.1 Overview
  • 8.2.2 Diagnostics: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Immunology
  • 8.3.1 Overview
  • 8.3.2 Immunology: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Cancer
  • 8.4.1 Overview
  • 8.4.2 Cancer: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Glycomics Market Analysis – by End User

9.1 Pharmaceutical & Biotechnology Companies
  • 9.1.1 Overview
  • 9.1.2 Cancer: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Academic & Research Institutes
  • 9.2.1 Overview
  • 9.2.2 Cancer: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Contract Research Organizations
  • 9.3.1 Overview
  • 9.3.2 Cancer: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Glycomics Market – North America Analysis

10.1 North America
  • 10.1.1 North America Glycomics Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Glycomics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Glycomics Market Breakdown, by Product
    • 10.1.1.1.2 US: North America Glycomics Market Breakdown, by Application
    • 10.1.1.1.3 US: North America Glycomics Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Glycomics Market Breakdown, by Product
    • 10.1.1.2.2 Canada: North America Glycomics Market Breakdown, by Application
    • 10.1.1.2.3 Canada: North America Glycomics Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Glycomics Market Breakdown, by Product
    • 10.1.1.3.2 Mexico : North America Glycomics Market Breakdown, by Application
    • 10.1.1.3.3 Mexico : North America Glycomics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Glycomics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Agilent Technologies, Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bruker Corporation
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 MERCK KGaA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 New England Biolabs
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 S-BIO (Sumitomo Bakelite Co., Ltd.)
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Shimadzu Corporation
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Takara Bio Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Thermo Fisher Scientific Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Waters Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Glycomics Market

  1. Agilent Technologies, Inc.
  2. Bruker Corporation
  3. MERCK KGaA
  4. New England Biolabs
  5. S-BIO (Sumitomo Bakelite Co., Ltd.)
  6. Shimadzu Corporation
  7. Takara Bio Inc.
  8. Thermo Fisher Scientific Inc.
  9. Waters Corporation  
north-america-glycomics-market